We serve Chemical Name:Ethyl 4,6-dihydroxy-5-nitronicotinate CAS:6317-97-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Ethyl 4,6-dihydroxy-5-nitronicotinate
CAS.NO:6317-97-1
Synonyms:T6NJ BQ CNW DQ EVO2;4,6-Dihydroxy-5-nitropyridine-3-carboxylic acid ethyl ester;3-Pyridinecarboxylic acid, 4,6-dihydroxy-5-nitro-, ethyl ester;4,6-Dihydroxy-5-nitronicotinic acid ethyl ester;Ethyl 4,6-dihydroxy-5-nitronicotinate;ethyl 4-hydroxy-5-nitro-6-oxo-1H-pyridine-3-carboxylate
Molecular Formula:C8H8N2O6
Molecular Weight:228.159
HS Code:2933399090
Physical and Chemical Properties:
Melting point:243-246ºC
Boiling point:468.7±40.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.618
PSA:125.47000
Exact Mass:228.038239
LogP:-0.06
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like T6NJ BQ CNW DQ EVO2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 4-hydroxy-5-nitro-6-oxo-1H-pyridine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ethyl 4,6-dihydroxy-5-nitronicotinate Use and application,T6NJ BQ CNW DQ EVO2 technical grade,usp/ep/jp grade.
Related News: After recently opening one cell therapy plant and breaking ground on another in Massachusetts, Takeda is pivoting westward to beef up production in California. (S)-(+)-2-Anisylglycin manufacturers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, 7-Brom-3.4-benzotropolon-acetat suppliers The green light converts the companies’ accelerated approval to a full approval for endometrial cancer that’s not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and for patients whose tumors have progressed following prior treatment. L-Leucine, D-tryptophyl-L-isoleucyl- vendor & factory Biocatalytic processing offers many advantages over using conventional metal catalysts. The superior enantio- and regioselectivity of enzymes results in higher yields of purer product—typically comprising just a single enantiomer that has been modified on only a specific site. ,Bluebird also earned an approval Wednesday in Europe for its gene therapy Lenti-D for children with early cerebral adrenoleukodystrophy and an ABCD1 genetic mutation without a matched sibling donor.
